Laparoscopic second look operation for ovarian cancer: Single center experiences

References

• LeBlanc E, Querleu D, Narducci F, Occelli B, Papageorgiou T, Sonoda Y. Laparoscopic restaging of early stage invasive adnexal tumors; a 10-year experience. Gynecol Oncol. 2004;94:624–9.
   PubMed Web of Science ®Google Scholar
• Chi DS, Abu-Rustum NR, Sonoda Y, Awtrey C, Hummer A, Venkatraman ES, Ten-year experience with laparoscopy on a gynecologic oncology service: Analysis of risk factors for complications and conversion to laparotomy. Am J Obstet Gynecol. 2004;191:1138–45.
   PubMed Web of Science ®Google Scholar
• Querleu D, Papageorgiou TH, Lambaudie E, Sonoda Y, Narducci F, LeBlanc E. Laparoscopic restaging of borderline ovarian tumors: results of 30 cases initially presumed as stage IA borderline ovarian tumors. BJOG 2003;110:201–4.
   PubMed Web of Science ®Google Scholar
• Ovarian Cancer. Screening, treatment, and follow-up. NIH consensus conference. JAMA 1995:491–7.
   Web of Science ®Google Scholar
• Copeland LJ, Gershenson DM, Wharton JT, Atkinson EN, Sneiqe N, Edwards CL, Microscopic disease at second-look laparotomy in advanced ovarian cancer. Cancer 1985;55:472–8.
   PubMed Web of Science ®Google Scholar
• Gershenson DM, Copeland LJ, Wharton JT, Atkinson EN, Sneiqe N, Edwards CL, Prognosis of surgically determined complete responders in advanced ovarian cancer. Cancer 1985;55:1129–35.
   PubMed Web of Science ®Google Scholar
• Luesley D, Lawton F, Blackledge G.. Failure of second look laparotomy to influence survival in epithelial ovarian cancer. Lancet 1988;2:599–603.
   PubMed Web of Science ®Google Scholar
• Freidman JB, Weiss NS. Second thoughts about second-look laparotomy in advanced ovarian cancer. N Eng J Med. 1990;322:1079–82.
   PubMed Web of Science ®Google Scholar
• Berek JS. Second-look versus second-nature. Gyecol Oncol. 1992;44:1–2.
   PubMed Web of Science ®Google Scholar
• Prayer L, Kainz C, Kramer J, Stiqlbauer R, Schurawitzki H, Baldt M, CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer. J comput-Assist Tomogr. 1993;17:626–32.
   PubMed Web of Science ®Google Scholar
• Forstner R, Hricak H, Ccchipinti KA, Powekk CB, Frankel SD, Stern JL. Ovarian cancer: staging with CT and MR imaging. Radiology 1995;197:619–26.
   PubMed Web of Science ®Google Scholar
• Kurtz AB. Tsimikas JV, Tempany CM, Hamper UM, Arger PG, Bree RL. Diganosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis–report of the Radiology Diagnostic Oncology Group. Radiology 1999;212:19–27.
   PubMed Web of Science ®Google Scholar
• Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities- report from the Radiological Diagnostic Oncology Group. Radiology 2000;215:761–7.
   PubMed Web of Science ®Google Scholar
• Low RN, Semelka RC, Worawattanakul S, Alzate GD, Sigeti JS. Extrahepatic abdominal imaging in aging and helical CT, with subsequent surgical correlation. Radiology 1999;210:625–32.
   PubMed Web of Science ®Google Scholar
• Low RN, Saleh F, Song SY, Shiftan TA, Barone RM, Lacey CG, Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination – a longitudinal study. Radiology 1999;211:519–28.
   PubMed Web of Science ®Google Scholar
• Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, 2-[fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol. 2001;83:391–2.
   Web of Science ®Google Scholar
• Kubik-Huch RA, Dorffler W, von Schulthess GK, Marince B, Kochli OR, Seifert B, Value of (18F)-FDG positron emission tomography,computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol. 2000;10:761–7.
   PubMed Web of Science ®Google Scholar
• Karlan BY, Hawkins R, Hoh C, Lee M, Tse N, Cane P, Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol. 1993;51:175–81.
   PubMed Web of Science ®Google Scholar
• Cho SM, Ha HK, Byun JY, Lee JM, Kim CJ, Nam Koong SE, Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR Am J Roentgenol. 2002;179:391–5.
   PubMed Web of Science ®Google Scholar
• Abu-Rustum NR, Barakat RR, Siegel PL, Venkatraman E, Curtin JP, Hoskins WJ. Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy? Obstet Gynecol. 1996;884:549–53.
   Google Scholar
• Husain A, Chi DS, Prasad M, Abu-Rustumz N, Barakat RR, Brown CL, The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol. 2001;80:44–7.
   Google Scholar
• Clough K, Ladonne JM, Nos C, Renolleau C, Validire P, Durand JC. Second look for ovarian cancer: laparoscopy or laparotomy? A prospective comparative study. Gynecol Oncol. 1999;72:411–17.
   PubMed Web of Science ®Google Scholar
• Berek JS, Griffith CT, Leventhal JM. Laparoscopy for second-look evaluation in ovarian cancer. Obstet Gynecol. 1981;58:192–8.
   PubMed Web of Science ®Google Scholar
• Lele S, Piver MS. Interval laparoscopy prior to second-look laparotomy in ovarian cancer. Obstet Gynecol. 1986;68:345–9.
   PubMed Web of Science ®Google Scholar
• Russo A, Cirelli G, Cassese E, Delli Ponti D, Sgambata R, Cecere F, Second-look in ovarian cancer: laparoscopy or laparotomy? Minerva Ginecol. 2001;53:146–54.
   PubMedGoogle Scholar
• Husain A, Chi DS, Prasad M, Abu-Rustum N, Barakat RR, Brown CL, The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol. 2001;80:44–7.
   Google Scholar
• Littell RD, Hallonquist H, Matulonis U, Seiden MV, Berkowitz RS, Duska LR. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol. 2006;103:570–4.
   PubMed Web of Science ®Google Scholar